SEC Form 3 · accession 0001127602-19-007178
AVIENT CORP · AVNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert T Bindner
Officer — SVP, President of PP&S
Period of report
Feb 18, 2019
Accepted (ET)
Feb 20, 2019 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001122976
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 25,356 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | holding | — | — | — | — | Feb 15, 2020 | Common Stock | 1,513 | — | D |
| Restricted Stock UnitsF3,F2 | — | holding | — | — | — | — | Feb 14, 2021 | Common Stock | 1,244 | — | D |
| Restricted Stock UnitsF4,F2 | — | holding | — | — | — | — | Dec 1, 2021 | Common Stock | 3,019 | — | D |
| Restricted Stock UnitsF5,F2 | — | holding | — | — | — | — | Feb 11, 2022 | Common Stock | 3,700 | — | D |
| Stock Appreciation RightsF6 | $14.61 | holding | — | — | — | — | Feb 14, 2022 | Common Stock | 3,000 | — | D |
| Stock Appreciation RightsF7 | $23.08 | holding | — | — | — | — | Feb 15, 2023 | Common Stock | 2,600 | — | D |
| Stock Appreciation RightsF8 | $35.07 | holding | — | — | — | — | Feb 11, 2024 | Common Stock | 2,400 | — | D |
| Stock Appreciation RightsF9 | $38.27 | holding | — | — | — | — | Feb 4, 2025 | Common Stock | 3,350 | — | D |
| Stock Appreciation RightsF10 | $24.98 | holding | — | — | — | — | Feb 10, 2026 | Common Stock | 4,520 | — | D |
| Stock Appreciation RightsF11 | $34.10 | holding | — | — | — | — | Feb 15, 2027 | Common Stock | 4,400 | — | D |
| Stock Appreciation RightsF12 | $41.89 | holding | — | — | — | — | Feb 14, 2028 | Common Stock | 3,480 | — | D |
| Stock Appreciation RightsF13 | $31.54 | holding | — | — | — | — | Feb 11, 2029 | Common Stock | 11,500 | — | D |
Explanation of responses
- F1The restricted stock units vest 3 years from the grant date on February 15, 2020.
- F10SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.
- F11SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $34.10 per share and no more than one-third of the grant can vest per year during the first three years.
- F12SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.
- F13SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.
- F2The restricted stock units include all dividend equivalents acquired since the date of grant. Dividend equivalents are subject to the same restrictions as the underlying grant of restricted stock units.
- F3The restricted stock units vest 3 years from the grant date on February 14, 2021.
- F4The restricted stock units vest 3 years from the grant date on December 1, 2021.
- F5The restricted stock units vest 3 years from the grant date on February 11, 2022.
- F6SARs become exercisable and vest one-third on the attainment of 10%, 15% and 20% stock appreciation (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $14.61 per share, with no more than one-third vesting per year during the first three years.
- F7SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $23.08 per share and no more than one-third of the grant can vest per year during the first three years.
- F8SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years.
- F9SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.